Literature DB >> 625710

Palate development after fetal tongue removal in cortisone-treated mice.

B E Walker, A Patterson.   

Abstract

Morphological studies of cortisone-induced cleft palate have shown retardation in the rotation of palatine shelves from a sagittal to a transverse plane. Cortisone also reduces fetal muscular movements, which may explain why displacement of the tongue from between the palatine shelves is delayed. Previous work with extrauterine development of control fetuses demonstrated that fetal membranes and tongue were major obstacles to shelf rotation. Thus, removal of these obstacles might permit rotation and fusion of palatine shelves in cortisone-treated fetuses. In the present experiment, fetuses from cortisone-treated strain CD-1 mice were released from uterus and membranes and allowed to develop for eight hours in a fluid medium with the umbilical cord left intact. Compared to 4% fusion in utero, there was palatal fusion in 20% of fetuses released from membranes. When the fetal tongue was removed during extrauterine development, the frequency of fusions increased to 61%. Fusion appeared normal by the criteria applicable through light microscopy. Thus, cortisone induces cleft palate primarily through interference with shelf rotation. The palatine shelves of treated fetuses retain their ability to fuse when they can come in contact during the normal time for palate closure.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 625710     DOI: 10.1002/tera.1420170112

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  3 in total

1.  An improved culture system for secondary palatal elevation.

Authors:  C A Lewis; L Thibault; R M Pratt; L L Brinkley
Journal:  In Vitro       Date:  1980-06

2.  Development of a suspension organ culture of the fetal rat palate.

Authors:  N al-Obaidi; U Kastner; H J Merker; S Klug
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Glucocorticoid-induced phospholipase A2-inhibitory proteins mediate glucocorticoid teratogenicity in vitro.

Authors:  C Gupta; M Katsumata; A S Goldman; R Herold; R Piddington
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.